One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™
Condition(s):Metastatic Prostate CancerLast Updated:November 19, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Prostate CancerLast Updated:November 19, 2021Completed
Condition(s):Prostate CancerLast Updated:January 8, 2018Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 13, 2023Active, not recruiting
Condition(s):Castrate-resistant Prostate CancerLast Updated:March 27, 2018Terminated
Condition(s):21-hydroxylase DeficiencyLast Updated:February 28, 2014Completed
Condition(s):Castration-resistant Prostate CancerLast Updated:March 5, 2024Active, not recruiting
Condition(s):Prostatic NeoplasmsLast Updated:March 27, 2014Completed
Condition(s):Prostate Cancer; Metastatic Cancer; Hormone Sensitive Prostate Cancer; Castration-resistant Prostate CancerLast Updated:January 8, 2024Active, not recruiting
Condition(s):HealthyLast Updated:January 20, 2016Completed
Condition(s):Salivary Glands TumorsLast Updated:March 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.